{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:06:24Z","timestamp":1773983184500,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Big Data"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although Parkinson\u2019s disease (PD) has a heterogeneous disease course, it remains challenging to establish subtypes. We described and clustered the natural course of Parkinson\u2019s disease (PD) with respect to functional disability and mortality. This retrospective cohort study utilized the Korean National Health Insurance Service database, which contains the social support registry database for patients with PD. We extracted patients newly diagnosed with PD in 2009 and followed them up until the end of 2018. Functional disability was assessed based on the long-term care insurance (LTCI) and National Disability Registry data. Further, we measured all-cause mortality during the observation period. We included 2944 eligible patients. The surviving patients were followed up for 113.7\u2009\u00b1\u20093.3 months. Among the patients who died, patients with and without disability registration were followed up for 61.4\u2009\u00b1\u200930.1 and 43.2\u2009\u00b1\u200932.0 months, respectively. The cumulative survival rate was highest in cluster 1 and decreased from Cluster 1 to Cluster 6. In the multivariable Cox regression analysis, the defined clusters were significantly associated with increased long-term mortality (adjusted hazard ratio [aHR], 3.440; 95% confidence interval [CI], 3.233\u20133.659; p\u2009&lt;\u20090.001). Further, age (aHR, 1.038; 95% CI, 1.031\u20131.045; p\u2009&lt;\u20090.001), diabetes (aHR, 1.146; 95% CI, 1.037\u20131.267; p\u2009=\u20090.007), and chronic kidney disease (aHR, 1.382; 95% CI, 1.080\u20131.768; p\u2009=\u20090.010) were identified as independent risk factors for increased risk of long-term mortality. Contrastingly, the female gender (aHR, 0.753; 95% CI, 0.681\u20130.833; p\u2009&lt;\u20090.001) and a higher LTCI grade (aHR, 0.995; 95% CI, 0.992\u20130.997; p\u2009&lt;\u20090.001) were associated with a significantly decreased long-term mortality risk. We identified six clinical course clusters for PD using longitudinal data regarding the social support registry and mortality. Our results suggest that PD progression is heterogeneous in terms of disability and mortality.<\/jats:p>","DOI":"10.1186\/s40537-023-00819-z","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T11:02:34Z","timestamp":1694257354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Classification of long-term clinical course of Parkinson\u2019s disease using clustering algorithms on social support registry database"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1288-470X","authenticated-orcid":false,"given":"Dougho","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1072-8452","authenticated-orcid":false,"given":"Su Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2594-1048","authenticated-orcid":false,"given":"Jong Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5310-4802","authenticated-orcid":false,"given":"Hyoung Seop","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,9]]},"reference":[{"issue":"6","key":"819_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson\u2019s disease. Lancet Neurol. 2006;5(6):525\u201335.","journal-title":"Lancet Neurol"},{"key":"819_CR2","doi-asserted-by":"publisher","first-page":"826193","DOI":"10.3389\/fncel.2022.826193","volume":"16","author":"A Ni","year":"2022","unstructured":"Ni A, Ernst C. Evidence that Substantia Nigra Pars Compacta dopaminergic neurons are selectively vulnerable to oxidative stress because they are highly metabolically active. Front Cell Neurosci. 2022;16:826193.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"819_CR3","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.1038\/s41598-022-09657-0","volume":"12","author":"EA Pelzer","year":"2022","unstructured":"Pelzer EA, Sturmer S, Feis DL, Melzer C, Schwartz F, Scharge M, et al. Clustering of Parkinson subtypes reveals strong influence of DRD2 polymorphism and gender. Sci Rep. 2022;12(1):6038.","journal-title":"Sci Rep"},{"key":"819_CR4","doi-asserted-by":"crossref","unstructured":"De Pablo-Fern\u00e1ndez E, Lees AJ, Holton JL, Warner TT. Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease. JAMA Neurol. 2019;76(4).","DOI":"10.1001\/jamaneurol.2018.4377"},{"key":"819_CR5","first-page":"9131474","volume":"2020","author":"Z Pirtosek","year":"2020","unstructured":"Pirtosek Z, Bajenaru O, Kovacs N, Milanov I, Relja M, Skorvanek M. Update on the management of Parkinson\u2019s disease for general neurologists. Parkinsons Dis. 2020;2020:9131474.","journal-title":"Parkinsons Dis"},{"issue":"2","key":"819_CR6","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1212\/WNL.0000000000006737","volume":"92","author":"S Prange","year":"2019","unstructured":"Prange S, Danaila T, Laurencin C, Caire C, Metereau E, Merle H, et al. Age and time course of long-term motor and nonmotor complications in Parkinson disease. Neurology. 2019;92(2):e148\u2013e60.","journal-title":"Neurology"},{"key":"819_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.parkreldis.2018.02.001","volume":"51","author":"KL Chou","year":"2018","unstructured":"Chou KL, Stacy M, Simuni T, Miyasaki J, Oertel WH, Sethi K, et al. The spectrum of off in Parkinson\u2019s disease: what have we learned over 40 years? Parkinsonism Relat Disord. 2018;51:9\u201316.","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"819_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18(7):435\u201350.","journal-title":"Nat Rev Neurosci"},{"issue":"13","key":"819_CR9","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/mds.25898","volume":"29","author":"AD Macleod","year":"2014","unstructured":"Macleod AD, Taylor KSM, Counsell CE. Mortality in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1615\u201322.","journal-title":"Mov Disord"},{"key":"819_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.parkreldis.2017.05.022","volume":"41","author":"M Moscovich","year":"2017","unstructured":"Moscovich M, Boschetti G, Moro A, Teive HAG, Hassan A, Munhoz RP. Death certificate data and causes of death in patients with parkinsonism. Parkinsonism Relat Disord. 2017;41:99\u2013103.","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"819_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.parkreldis.2010.04.010","volume":"16","author":"S Pennington","year":"2010","unstructured":"Pennington S, Snell K, Lee M, Walker R. The cause of death in idiopathic Parkinson\u2019s disease. Parkinsonism Relat Disord. 2010;16(7):434\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"16","key":"819_CR12","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1002\/mds.22341","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Nutt JG, Stebbins GT. The Unified Dyskinesia Rating Scale: presentation and clinimetric profile. Mov Disord. 2008;23(16):2398\u2013403.","journal-title":"Mov Disord"},{"issue":"2","key":"819_CR13","doi-asserted-by":"publisher","first-page":"e57221","DOI":"10.1371\/journal.pone.0057221","volume":"8","author":"K Ray Chaudhuri","year":"2013","unstructured":"Ray Chaudhuri K, Rojo JM, Schapira AH, Brooks DJ, Stocchi F, Odin P, et al. A proposal for a comprehensive grading of Parkinson\u2019s disease severity combining motor and non-motor assessments: meeting an unmet need. PLoS ONE. 2013;8(2):e57221.","journal-title":"PLoS ONE"},{"issue":"4","key":"819_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11910-017-0738-x","volume":"17","author":"SM Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad SM, Postuma RB. Subtypes of Parkinson\u2019s disease: what do they tell us about disease progression? Curr Neurol Neurosci Rep. 2017;17(4):34.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"7","key":"819_CR15","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","volume":"140","author":"SM Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB. Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression. Brain. 2017;140(7):1959\u201376.","journal-title":"Brain"},{"issue":"6","key":"819_CR16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323(6):548\u201360.","journal-title":"JAMA"},{"issue":"2","key":"819_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JPD-202472","volume":"11","author":"TA Mestre","year":"2021","unstructured":"Mestre TA, Fereshtehnejad S-M, Berg D, Bohnen NI, Dujardin K, Erro R, et al. Parkinson\u2019s disease subtypes: critical appraisal and recommendations. J Parkinson\u2019s Disease. 2021;11(2):395\u2013404.","journal-title":"J Parkinson\u2019s Disease"},{"issue":"3","key":"819_CR18","first-page":"799","volume":"46","author":"S Cheol Seong","year":"2017","unstructured":"Cheol Seong S, Kim YY, Khang YH, Heon Park J, Kang HJ, Lee H, et al. Data resource profile: the national health information database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46(3):799\u2013800.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"819_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4093\/dmj.2014.38.5.395","volume":"38","author":"SO Song","year":"2014","unstructured":"Song SO, Jung CH, Song YD, Park CY, Kwon HS, Cha BS, et al. Background and data configuration process of a nationwide population-based study using the korean national health insurance system. Diabetes Metab J. 2014;38(5):395\u2013403.","journal-title":"Diabetes Metab J"},{"issue":"3","key":"819_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4235\/agmr.20.0036","volume":"24","author":"H Ga","year":"2020","unstructured":"Ga H. Long-term care system in Korea. Ann Geriatr Med Res. 2020;24(3):181\u20136.","journal-title":"Ann Geriatr Med Res"},{"issue":"1","key":"819_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.healthpol.2020.11.003","volume":"125","author":"H Kim","year":"2021","unstructured":"Kim H, Kwon S. A decade of public long-term care insurance in South Korea: policy lessons for aging countries. Health Policy. 2021;125(1):22\u20136.","journal-title":"Health Policy"},{"issue":"6","key":"819_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v061.i06","volume":"61","author":"M Charrad","year":"2014","unstructured":"Charrad M, Ghazzali N, Boiteau V, Niknafs A, NbClust. An R package for determining the relevant number of clusters in a data set. J Stat Softw. 2014;61(6):1\u201336.","journal-title":"J Stat Softw"},{"key":"819_CR23","doi-asserted-by":"crossref","unstructured":"Khasawneh MT, Hendricks RM. A systematic review of Parkinson\u2019s disease cluster analysis research. Aging and Disease. 2021;12(7).","DOI":"10.14336\/AD.2021.0519"},{"issue":"2","key":"819_CR24","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/mds.28321","volume":"36","author":"D Belvisi","year":"2021","unstructured":"Belvisi D, Fabbrini A, De Bartolo MI, Costanzo M, Manzo N, Fabbrini G, et al. The pathophysiological correlates of Parkinson\u2019s disease clinical subtypes. Mov Disord. 2021;36(2):370\u20139.","journal-title":"Mov Disord"},{"issue":"12","key":"819_CR25","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/jnnp-2018-318337","volume":"89","author":"M Lawton","year":"2018","unstructured":"Lawton M, Ben-Shlomo Y, May MT, Baig F, Barber TR, Klein JC, et al. Developing and validating Parkinson\u2019s disease subtypes and their motor and cognitive progression. J Neurol Neurosurg Psychiatry. 2018;89(12):1279\u201387.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"819_CR26","doi-asserted-by":"publisher","first-page":"e0233296","DOI":"10.1371\/journal.pone.0233296","volume":"15","author":"S Krishnagopal","year":"2020","unstructured":"Krishnagopal S, Coelln RV, Shulman LM, Girvan M. Identifying and predicting Parkinson\u2019s disease subtypes through trajectory clustering via bipartite networks. PLoS ONE. 2020;15(6):e0233296.","journal-title":"PLoS ONE"},{"key":"819_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ejmp.2019.12.022","volume":"69","author":"MR Salmanpour","year":"2020","unstructured":"Salmanpour MR, Shamsaei M, Saberi A, Klyuzhin IS, Tang J, Sossi V, et al. Machine learning methods for optimal prediction of motor outcome in Parkinson\u2019s disease. Phys Med. 2020;69:233\u201340.","journal-title":"Phys Med"},{"issue":"1","key":"819_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/archneurol.2009.295","volume":"67","author":"LM Shulman","year":"2010","unstructured":"Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ. The clinically important difference on the unified Parkinson\u2019s disease rating scale. Arch Neurol. 2010;67(1):64\u201370.","journal-title":"Arch Neurol"},{"issue":"1","key":"819_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41531-022-00320-z","volume":"8","author":"MC Gonzalez","year":"2022","unstructured":"Gonzalez MC, Dalen I, Maple-Grodem J, Tysnes OB, Alves G. Parkinson\u2019s disease clinical milestones and mortality. NPJ Parkinsons Dis. 2022;8(1):58.","journal-title":"NPJ Parkinsons Dis"},{"issue":"30","key":"819_CR30","doi-asserted-by":"publisher","first-page":"e4337","DOI":"10.1097\/MD.0000000000004337","volume":"95","author":"F Yang","year":"2016","unstructured":"Yang F, Johansson ALV, Pedersen NL, Fang F, Gatz M, Wirdefeldt K. Socioeconomic status in relation to Parkinson\u2019s disease risk and mortality: a population-based prospective study. Med (Baltim). 2016;95(30):e4337.","journal-title":"Med (Baltim)"},{"issue":"1","key":"819_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/ner.12324","volume":"19","author":"G Genc","year":"2016","unstructured":"Genc G, Abboud H, Oravivattanakul S, Alsallom F, Thompson NR, Cooper S, et al. Socioeconomic status may impact functional outcome of deep brain stimulation surgery in Parkinson\u2019s disease. Neuromodulation. 2016;19(1):25\u201330.","journal-title":"Neuromodulation"},{"key":"819_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-030-85292-4_12","volume":"134","author":"M Serra-Burriel","year":"2022","unstructured":"Serra-Burriel M, Ames C. Machine learning-based clustering analysis: foundational concepts, methods, and applications. Acta Neurochir Suppl. 2022;134:91\u2013100.","journal-title":"Acta Neurochir Suppl"},{"issue":"6","key":"819_CR33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0165025409343765","volume":"33","author":"N Ram","year":"2009","unstructured":"Ram N, Grimm KJ. Growth mixture modeling: a method for identifying differences in longitudinal change among unobserved groups. Int J Behav Dev. 2009;33(6):565\u201376.","journal-title":"Int J Behav Dev"},{"issue":"1","key":"819_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12874-021-01276-z","volume":"21","author":"JY Kwon","year":"2021","unstructured":"Kwon JY, Sawatzky R, Baumbusch J, Lauck S, Ratner PA. Growth mixture models: a case example of the longitudinal analysis of patient-reported outcomes data captured by a clinical registry. BMC Med Res Methodol. 2021;21(1):79.","journal-title":"BMC Med Res Methodol"}],"container-title":["Journal of Big Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40537-023-00819-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40537-023-00819-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40537-023-00819-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T10:45:10Z","timestamp":1700563510000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalofbigdata.springeropen.com\/articles\/10.1186\/s40537-023-00819-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,9]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1186\/s40537-023-00819-z","relation":{},"ISSN":["2196-1115"],"issn-type":[{"value":"2196-1115","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,9]]},"assertion":[{"value":"23 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was reviewed and approved by the Institutional Review Board of National Health Insurance Service Ilsan Hospital (NHIS-2023-02-002). Informed consent was waived due to the retrospective study design and anonymity of the National Health Insurance Service database.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"140"}}